Methods:
We included 241 adults with euthymic BD in a multicenter cross-sectional study. 6 We used a battery of tests to assess six cognition domains. A path analysis was then used to 7 perform a mediation analysis of the relationship between residual depressive symptoms, 8 cognitive components, and functioning. Bipolar disorders (BD) are highly disabling (1) and prevalent (2). More than half the 2 individuals with BD experience significant functional impairment in several domains, such as 3 family and social life and work, outside the acute phases of the illness (3). In the last decade, 4 the focus of research in BD has changed from clinical remission to functional recovery (3). 5 However, the sources of high variation observed in the psychosocial functioning of 6 individuals with BD are still poorly understood. Cognitive impairment is an important 7 determinant of functional impairment in BD (4). Because the strength of association between 8 poor social functioning and cognitive impairment in BD is similar to that seen in 9 schizophrenia (5), it seems crucial to characterize the underlying architecture of cognitive 10 performance in BD. 11 Previous studies investigating multiple cognitive areas in BD have usually focused on 12 domains a priori that were subjectively defined and selected. However, the validity of these 13 domains is questionable, as it relies on the assumption that the latent organization of human 14 cognition is similar in persons with BD and healthy controls. This crucial assumption has 15 received few experimental evidence (6). It thus remains possible that the same 16 neuropsychological tests might evaluate different cognitive competencies in these two groups 17 of participants if there is a discrepancy in how cognitive measures relate to one another 18 between individuals with and without BD. This lack of equivalence between the constructs 19 could lead to artifacts in the observed differences in cognitive test performances. A few 20 studies have explored the latent cognitive structure in BD and found that cognitive 21 functioning was best described by multi-factorial models (6-8). However, some of these 22 studies included symptomatic patients (7, 8) . Here, we have measured performance for a 23 broad range of cognitive domains in euthymic BD using a comprehensive battery of 24 neuropsychological tests. We have examined the component structure of BD cognitive 25 8 processes using a Principal Component Analysis, which allows the data-driven reduction of 1 multiple cognitive measures, avoids arbitrary and a priori categorization of several tests into 2 domains, and results in a reliable estimate of underlying cognitive constructs in BD. 3 Among clinical factors, residual depressive symptoms have been reported to be the 4 strongest predictor of functional impairment (9) and quality of life (10) in euthymic BD. They 5 are also associated with lower adherence to medication in BD (11). In contrast, residual 6 hypomanic symptoms have no impact on functioning in euthymic BD (4, 9, (12) (13) (14) . Whereas 7 residual hypomanic symptoms are not related to cognition (15), it is less clear whether 8 subthreshold depressive symptoms negatively affect neuropsychological performance in 9 euthymic BD or not. The relationship between residual depressive symptoms and cognition is 10 mixed, showing a small impact of subthreshold depression on only a few cognitive 11 components, such as verbal memory, speed, and executive function, but not for others (16) . A 12 few studies have explored the role of cognition in mediating the relationship between 13 depressive symptoms and functioning in euthymic BD, leading to inconsistent results. One 14 study showed that verbal memory partially mediated the relationship between subthreshold 15 depressive symptoms and functional outcome in euthymic people with BD (17). However, the 16 sample size was not large enough to include other cognitive moderators in the model. In The age at onset; number of previous mixed, hypomanic, manic, and major depressive 4 episodes; subtype of BD; and history of psychotic symptoms were recorded. We used the 5 yes/no format for recording whether the patient was taking lithium carbonate, anticonvulsants, 6 antipsychotics, antidepressants, or anxiolytics at the time of the evaluation. Finally, three 7 socio-demographic characteristics were collected: sex, age, and educational level. 8 Psychosocial functioning was measured using the Functioning Assessment Short Test 9 (FAST), which covers six functioning domains: autonomy, occupational functioning, 10 cognitive functioning, financial issues, interpersonal relationships, and leisure time (21). The 11 higher the score, the greater the disability. FAST has good internal consistency (Cronbach 12 alpha between 0.87 and 0.96) and test-retest reliability (Pearson correlation coefficient 13 between 0.90 and 0.97; intraclass correlation coefficient between 0.90 and 0.98, see 14 Supplemental References S1 for a bibliography of FAST psychometrical properties). fluency, number of recalled words in the immediate recall, short, and long delay free recall of 20 the CVLT, number of total correct recognized words for the CVLT, span lengths for the 21 forward and backward conditions of the spatial and digit span tests, number of correct 22 answers for matrix reasoning, and total score for vocabulary. 23 Sampling adequacy was evaluated using the Kaiser-Meyer-Olkin (KMO) measure (28) for the 24 overall cognitive data set and Bartlett's test of sphericity (29). The number of components to 25 12 be extracted in the PCA was determined by Horn's parallel analysis (30). This method 1 contrasts eigenvalues produced through a parallel PCA on 1000 random datasets, with the 2 same number of variables and observations as the observational dataset, to generate 3 eigenvalues for components that are adjusted for sample error-induced inflation. Adjusted 4 eigenvalues > 1 indicate dimensions to retain. 5 We ran a PCA on cognitive variables followed by an Oblimin rotation. The rotation was 6 performed to simplify the component structure. We used an oblique rotation because the 7 cognitive components were believed to be correlated with each other. In PCA, the usual 8 standard for sample size is a participant-to-variable ratio > 5 (31), and therefore required 110 9 participants for the current study. The fit between the model and the data was assessed using four indices: the chi-square 3 goodness-of-fit statistic (χ²), comparative fit index (CFI), root-mean-squared error of 4 approximation (RMSEA), and standardized root mean square residual (SRMR). We included 241 patients. Table 1 reports their sociodemographic and clinical 10 characteristics and Table 2 the results of the battery of cognitive tests. No patient had more 11 than 5% missing cognitive data; the missing cognitive data were estimated using a 12 multivariate imputation by chained equations in the mice package of R. The KMO measure for the overall cognitive data set was 0.85 and Bartlett's test of 16 sphericity was significant (Χ²(231) = 2295, p < 0.001), both indicating good factorability of 17 the cognitive data. Horn's parallel analysis showed that five components should be retained, 18 as their adjusted eigenvalue was above 1 (see Supplemental Table S2 ). The 5-component 19 structure explained 61% of the variance (see Supplemental Table S3 ). All component loadings 20 were greater than 0.4, and all communalities were higher than 0.3 (see Table 3 ). The first The path analysis model is shown in Figure 1 . We represent neither covariances 10 between cognitive components, nor the regressions on covariates, to enhance readability.
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Path analysis requires at least 15 participants for each variable (33). We included ten 12 variables in the model and therefore required at least 150 participants. There were 0.8% 13 missing data, which were handled using the full information maximum likelihood estimation. 14 The four patterns of missingness are reported in Supplemental Table S5 and the covariance   15 coverage matrix of missing data in Supplemental Table S6 . 16 The model provided a good fit for the data, as suggested by the nonsignificant chi-17 square goodness-of-fit statistic (X²(4) = 7.5, p = 0.113), a CFI greater than 0.95 (0.989), an 18 RMSEA not significantly larger than 0.05 (RMSEA = 0.06, one-sided P value of the test of 19 the null hypothesis RMSEA = 0.05, 0. 329), and SRMR lower than 0.08 (0.017). 20 The model explained 30% of the variance in functioning. Altogether, the analysis 21 revealed the following relationships between the variables (Figure 1 Supplemental Table S7 . Here, we first used a PCA to identify the underlying architecture of cognitive processing 8 in euthymic patients with BD. We then used a path analysis to evaluate whether cognition 9 mediated the relationship between residual depressive symptoms and functioning. 10 We found five underlying components involved in cognition in euthymic BD. Two (7). The labels used in these previous studies to describe the cognitive dimensions were 25 similar to those applied in the current study, consisting of verbal memory, speed of 26 16 processing, working memory, executive functions, verbal knowledge, and attention 1 dimensions. This suggests a relative stability and reliability of the method we used to uncover 2 the underlying cognitive components in BD. 3 There was a negative association between residual depressive symptoms and 4 functioning: individuals with more pronounced depressive symptoms had a poorer social 5 functioning, which was not explained by age, sex, lower education, or poorer cognition. This 6 finding is in accordance with previous cross-sectional (13, 17, 18, 32) and longitudinal studies 7 (9, 14) , showing that subclinical depressive symptoms in bipolar disorders are the main 8 predictors of poor functional outcome, particularly work functioning (34). The present study 9 included only euthymic patients, based on stringent criteria: the mean score for depression 10 was very low but similar to previous studies exploring social functioning in euthymic BD (9, 11 13, 17, 32) . However, the data show that functional impairment may be associated with even 12 very low residual depressive symptoms, measured with a scale that was not specifically 13 designed to assess subsyndromal depressive symptoms. 14 Among the five cognitive components found in this study, only two were positively 15 associated with functioning: "verbal memory" and "verbal fluency and inhibition." Patients 16 with better verbal memory, verbal fluency and inhibition also had a better social functioning. 17 These results are consistent with several prior reports indicating that verbal memory (14) and 18 inhibitory control (Stroop Colour Word Test) (35) were more highly associated with 19 functioning than other cognitive functions. That functioning was more highly related to 20 residual depressive symptoms than cognition could be explained by the auto evaluation 21 method we used to measure everyday functioning. Self-reported measures of social 22 functioning may be influenced less by objective cognitive performance and more by 23 depressive symptomatology, due to a pessimistic subjective appraisal of oneself and one's 24 environment. This influence might be particularly important for low FAST scores (better 25 functioning), like in our sample, where the distribution of FAST scores was skewed on the 1 right. In contrast, the reverse may be true for performance-based measures of functioning and 2 real-world functional milestones in BD, which may be influenced more by objective cognitive 3 performance and less by depression (5, 12). 4 No associations between residual depressive symptoms and cognitive components were 5 significant, showing that cognition does not mediate the relationship between subclinical 6 residual depressive symptoms and functioning. This result is in accordance with a previous 7 study reporting that perceived cognitive impairment and subclinical residual depressive 8 symptoms are two independent sources of variation in the functioning of individuals with BD 9 (36). However, this mediation might occur for higher levels of depressive symptoms, as the 10 impact of depressive symptoms on cognition varied according to the clinical response after 11 treatment (37). 12 Our model explained only 30% of the variance in functioning, supporting a role for 13 other factors that were not measured here. Previous studies have suggested that functioning 14 may be impaired when sleep is persistently disrupted (38), when social cognition is impaired 15 (13), and when episode density is high (35). The mean level of functioning in participants 16 recruited in this study corresponds to moderate functional difficulties (3). It is in the range 17 (from 6 to 29) of those found in studies exploring the relationship between cognition and 18 functioning in euthymic BD (13, 32, 36) . This consistency supports the general applicability 19 of our findings to patients with euthymic BD, provided the same assessment tools are used. 20 21 Limitations of our study include the cross-sectional design, which precludes the 22 assessment of causality and the direction of potential causal links. Another limitation is the 23 lack of inclusion of social cognitive tasks in the assessment. We did not compare the 24 cognitive architecture found in the current sample of BD patients to a control group. Finally, 25 18 the sample size was not large enough to test a more complex model that includes other 1 variables of the illness (type of BD, number of previous episodes, age at onset, and history of 2 psychosis) and medication. The time since the last mood episode might also be an important 3 factor lacking in the present study. These variables might have also had an effect on 4 functioning in euthymic BD. 5 Our findings have important implications for future clinical studies. Individuals with 6 BD who respond to treatment may nevertheless continue to experience residual depressive 7 and cognitive symptoms, leading to difficulties in functioning. First, it seems crucial to 8 improving the assessment and the characterization of residual depressive symptoms, with for 9 example specific scales. Treatment approaches should possibly include the cognitive 10 performance improvement and the full residual depressive symptoms remission as important 11 targets to obtain functional recovery in BD. The optimal method to treat residual depressive 12 symptoms is not clear, but they may be targeted by the use of mood stabilizers effective in the 13 treatment of depressive polarity. Evidence for the efficacy of pharmacological and 14 psychological interventions that target cognitive deficits in BD is still preliminary, despite 15 promising avenues such as functional remediation (39). Among cognitive dimensions for 16 cognitive remediation in euthymic BD, our data suggest that verbal memory and fluency, and 17 inhibition may be choice targets. 18 In summary, this study provides further evidence that cognitive impairments in specific 19 dimensions are a core feature of BD. This study also suggests that cognition is a separable 20 dimension from depressive symptoms that persist during the inter-episodic period of BD. 
